INSIGHTS ON FACILITY DESIGN
-
![iStock-1153276321-lab-technology-check-quality]( "Demonstrating ROI For Increased Digital Plant Maturity")
Demonstrating ROI For Increased Digital Plant MaturityCytiva has partnered with the independent software company, Biopharm Services (BPS), to model the costs and associated benefits of increasing digital maturity for monoclonal antibody processes in a biopharma plant utilizing single-use technology.
-
![Pall Accelerator]( "Accelerator℠ Vision Platform")
Accelerator℠ Vision PlatformThe Pall Accelerator Vision Platform gives you the ability to create virtual replicas of process equipment displayed in your manufacturing facility.
-
![iStock-1214627273-development-lab]( "Cleanliness Is Next To Godliness In Medicinal Manufacturing")
Cleanliness Is Next To Godliness In Medicinal ManufacturingCleanrooms in the pharmaceutical, biotech, medical device, and life sciences industries reduce particulate contamination and control environmental parameters including temperature, humidity, and pressure.
-
![The Top Trends Influencing Automation In The Life Science Industry 2018]( "Never Too Early To Plan For Automation")
Never Too Early To Plan For AutomationEarly platform design selections can greatly affect your future automation flexibility and ability to show compliance throughout regulatory reviews.
-
The Impact Of Facility Design On The Safety Of Viral Vectors2/18/2022
It is critical to vet not just the expertise available at a CDMO, but also the effectiveness of their facility design to reduce risk and meet scale-up needs.
-
In-House Manufacturing: Key To Driving A Diabetes Vaccine?1/28/2022
Increasing constraints on today’s supply chain from the COVID-19 pandemic mean drug companies must secure strategies that can ensure product delivery in the face of these challenges.
-
Enabling Bioprocess Control With Successful Automation Strategies12/9/2021
In a recent live event with Bioprocess Online, industry experts at various stages of their automation journey discussed their approach to enhancing quality control and data integrity through automated technologies.
-
Biopharmaceuticals Development And Manufacturing: Wide-Ranging Expertise And Vertically Integrated Service11/17/2021
The company’s wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art cGMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing.
-
Modular Facilities - The Proven Response For Rapid Biomanufacturing Anywhere9/28/2021
Select one of the flexible, prefabricated cGMP biomanufacturing environment with a configurable production line that future-proofs capacity expansion, improves operational efficiency and minimizes infrastructure to begin manufacturing faster for a fraction of the cost.
FACILITY DESIGN SOLUTIONS
-
![mammalian]( "Mammalian Cell Culture Manufacturing")
Explore the new state-of-the-art manufacturing facility ready for clinical and commercial mammalian cGMP manufacturing.
-
![GettyImages-155373764-cryopreservation-cold-chain]( "Transport Simulation Laboratory")
The Transport Simulation Laboratory (TSL) consists of a large environmental chamber equipped with a control system, calibrated sensors, and a validated data collection system with mechanical and hydraulic equipment that can simulate a customized distribution environment profile.
-
![genderless-aseptiquik-l-series-connectors]( "Genderless AseptiQuik® L Series Connectors")
Genderless AseptiQuik® Large Format 3/4", 1" and 1½" sanitary Connectors enable quick and easy sterile connections, even in non-sterile environments. The easy-to-use genderless design simplifies system integration and minimizes the risk of operator error. The connector's robust construction provides enhanced user confidence and reliable performance without the need for clamps, fixtures or tube welders. Biopharmaceutical manufacturers benefit from a full range of interchangeable 3/4" to 1½" flow solutions for production environments with the quality and market availability they expect from the leader in single-use connection technology.
-
In biomanufacturing the only certainty is risk and the only constant is change. Technology is pushing new frontiers, new markets are opening up across the globe, and new competition is creating new levels of urgency—all under the ever more watchful eye of regulators.
-
To fulfill the increasing demand of life-saving solutions for patients' lives all over the world, we decided to drive forward with building our new facility, Plant 4. Our accumulated expertise is implemented with the latest technologies and innovation, so that Plant 4 will be able to serve as part of your global presence, becoming your future biomanufacturing hub.
